LOC105371870: A Potential Drug Target or Biomarker (G105371870)

LOC105371870: A Potential Drug Target or Biomarker

LOC105371870, also known as Uncharacterized LOC105371870 or X4, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The molecule is derived from the genomic region encoding the long non-coding RNA (lnc) gene X4.

LOC105371870 is characterized by its unique structure and sequence. It is composed of 20 exons that are arranged in a single exonic unit. The molecule has a length of approximately 200 nucleotides and an estimated molecular weight of 9.9 kilobases (kb).

The specific function of LOC105371870 is not yet fully understood, but its potential role in drug development is currently being investigated. Several studies have identified LOC105371870 as a potential drug target in the context of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key reasons for the interest in LOC105371870 is its potential to intervene in the development and progression of cancer. Several studies have shown that LOC105371870 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, the molecule has been shown to be involved in the regulation of cell cycle progression, which is a key factor in cancer development.

Another potential drug target for LOC105371870 is its role in neurodegenerative diseases. The molecule has been shown to be involved in the regulation of dendritin synthesis, which is a critical process in the development and progression of neurodegenerative diseases. Additionally, LOC105371870 has been shown to play a role in the regulation of axon growth and differentiation, which are also important processes in neurodegenerative diseases.

LOC105371870 may also be a potential biomarker for certain autoimmune disorders. The molecule has been shown to be involved in the regulation of immune cell function and has been implicated in the development of autoimmune disorders. Additionally, LOC105371870 has been shown to play a role in the regulation of inflammation, which is a key feature of many autoimmune disorders.

In conclusion, LOC105371870 is a highly characterized and promising molecule that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in the development and progression of disease and to determine its potential as a therapeutic intervention.

Protein Name: Uncharacterized LOC105371870

More Common Targets

LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988